Solicitation of Nominations for Appointment to the Advisory Committee on Breast Cancer in Young Women, 90699-90700 [2024-26784]

Download as PDF 90699 Federal Register / Vol. 89, No. 222 / Monday, November 18, 2024 / Notices programs, healthcare systems, and professional and advocacy organizations to guide program investments, provide up-to-date information on symptom presentation, healthcare utilization patterns, and patient recovery among others, and to provide information on prevention of TBI. Data obtained from this data collection are not available from currently existing databases, and the data needed for analysis cannot be added to existing data collection processes. This data collection will occur over three years. After each data collection year, findings will be reviewed to identify potential modifications to the methodology and survey for following year collection. Depending on the nature and scope of the improvements, a change request or a Revision package will be submitted to OMB for review and approval. CDC requests OMB approval for an estimated 5,656 annual burden hours. There is no cost to respondents other than their time to participate. ESTIMATED ANNUALIZED BURDEN HOURS Average burden per response (in hours) Number of responses per respondent Total burden (in hours) Form name Individuals and Households ....... Initial Invitation Letter .............................. Reminder Postcard ................................. Final Reminder Letter ............................. Text Message Reminder ......................... Screener .................................................. Survey, web ............................................ Survey, phone ......................................... 57,405 53,312 50,583 27,696 10,058 8,682 1,318 1 1 1 1 1 1 1 1/60 1/60 1/60 1/60 4/60 11/60 11/60 957 889 843 462 671 1592 242 Total .................................... ................................................................. ........................ ........................ ........................ 5,656 Jeffrey M. Zirger, Lead, Information Collection Review Office, Office of Public Health Ethics and Regulations, Office of Science, Centers for Disease Control and Prevention. [FR Doc. 2024–26777 Filed 11–15–24; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Solicitation of Nominations for Appointment to the Advisory Committee on Breast Cancer in Young Women Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS). AGENCY: ACTION: Notice. In accordance with the Federal Advisory Committee Act, the Centers for Disease Control and Prevention (CDC), within the Department of Health and Human Services (HHS), is seeking nominations for membership on the Advisory Committee on Breast Cancer in Young Women (ACBCYW). The ACBCYW consists of up to 15 experts in fields associated with breast cancer, disease prevention, early detection, diagnosis, public health, social marketing, genetic screening and counseling, treatment, rehabilitation, palliative care, and survivorship in young women, or in SUMMARY: lotter on DSK11XQN23PROD with NOTICES1 Number of respondents Type of respondent VerDate Sep<11>2014 17:17 Nov 15, 2024 Jkt 265001 related disciplines with a specific focus on young women. DATES: Nominations for membership on the ACBCYW must be received no later than December 16, 2024. Packages received after this time will not be considered for the current membership cycle. ADDRESSES: All nominations should be mailed to Kimberly E. Smith, M.B.A., M.H.A., c/o ACBCYW Secretariat, Centers for Disease Control and Prevention, 3719 North Peachtree Road, Building 100, Chamblee, Georgia 30341 or emailed to acbcyw@cdc.gov. FOR FURTHER INFORMATION CONTACT: Kimberly E. Smith, M.B.A., M.H.A., Designated Federal Officer, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, 4770 Buford Highway NE, Mailstop S107–4, Atlanta, Georgia 30341. Telephone: (404) 498–0073; Email: acbcyw@ cdc.gov. SUPPLEMENTARY INFORMATION: Nominations are sought for individuals who have the expertise and qualifications necessary to contribute to the accomplishment of the objectives of the Advisory Committee on Breast Cancer in Young Women (ACBCYW). Nominees will be selected based on expertise in the fields of breast health, breast cancer, disease prevention and risk reduction, survivorship (including metastatic breast cancer), hereditary breast and ovarian cancer, or in related disciplines with a specific focus on young women. Persons with personal PO 00000 Frm 00037 Fmt 4703 Sfmt 4703 experience with early onset breast cancer are also eligible to apply. This includes but may not be limited to breast cancer survivors 45 years of age or younger, and caregivers of said persons. Federal employees will not be considered for membership. Members may be invited to serve up to four-year terms. Selection of members is based on candidates’ qualifications to contribute to the accomplishment of ACBCYW objectives (https://www.cdc.gov/breastcancer/php/advisory-committee/). Department of Health and Human Services (HHS) policy stipulates that committee membership be balanced in terms of points of view represented and the committee’s function. Appointments shall be made without discrimination on the basis of age, race, ethnicity, gender, sexual orientation, gender identity, HIV status, disability, and cultural, religious, or socioeconomic status. Nominees must be U.S. citizens and cannot be full-time employees of the U.S. Government. Current participation on Federal workgroups or prior experience serving on a Federal advisory committee does not disqualify a candidate; however, HHS policy is to avoid excessive individual service on advisory committees and multiple committee memberships. Committee members are Special Government Employees, requiring the filing of financial disclosure reports at the beginning of and annually during their terms. The Centers for Disease Control and Prevention (CDC) reviews potential candidates for ACBCYW membership each year and provides a slate of E:\FR\FM\18NON1.SGM 18NON1 90700 Federal Register / Vol. 89, No. 222 / Monday, November 18, 2024 / Notices nominees for consideration to the Secretary of HHS for final selection. HHS notifies selected candidates of their appointment near the start of the term in December 2025, or as soon as the HHS selection process is completed. Note that the need for different expertise varies from year to year and a candidate who is not selected in one year may be reconsidered in a subsequent year. Candidates should submit the following items: D Current curriculum vitae, including complete contact information (telephone numbers, mailing address, email address). D At least one letter of recommendation from person(s) not employed by HHS. Candidates may submit letter(s) from current HHS employees if they wish, but at least one letter must be submitted by a person not employed by an HHS agency (e.g., CDC, National Institutes of Health, Food and Drug Administration). D A short biography (150 words or less). Nominations may be submitted by the candidate or by the person/organization recommending the candidate. The Director, Office of Strategic Business Initiatives, Office of the Chief Operating Officer, Centers for Disease Control and Prevention, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Kalwant Smagh, Director, Office of Strategic Business Initiatives, Office of the Chief Operating Officer, Centers for Disease Control and Prevention. [FR Doc. 2024–26784 Filed 11–15–24; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention [30Day–25–24FZ] lotter on DSK11XQN23PROD with NOTICES1 Agency Forms Undergoing Paperwork Reduction Act Review In accordance with the Paperwork Reduction Act of 1995, the Centers for Disease Control and Prevention (CDC) has submitted the information collection request titled ‘‘Annual Progress Reports for Injury Control Research Centers (ICRC)’’ to the Office of Management and Budget (OMB) for review and approval. CDC previously VerDate Sep<11>2014 17:17 Nov 15, 2024 Jkt 265001 published a ‘‘Proposed Data Collection Submitted for Public Comment and Recommendations’’ notice on June 4, 2024 to obtain comments from the public and affected agencies. CDC received one non-substantive comment related to the previous notice. This notice serves to allow an additional 30 days for public and affected agency comments. CDC will accept all comments for this proposed information collection project. The Office of Management and Budget is particularly interested in comments that: (a) Evaluate whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information will have practical utility; (b) Evaluate the accuracy of the agencies estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used; (c) Enhance the quality, utility, and clarity of the information to be collected; (d) Minimize the burden of the collection of information on those who are to respond, including, through the use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology, e.g., permitting electronic submission of responses; and (e) Assess information collection costs. To request additional information on the proposed project or to obtain a copy of the information collection plan and instruments, call (404) 639–7570. Comments and recommendations for the proposed information collection should be sent within 30 days of publication of this notice to www.reginfo.gov/public/ do/PRAMain. Find this particular information collection by selecting ‘‘Currently under 30-day Review—Open for Public Comments’’ or by using the search function. Direct written comments and/or suggestions regarding the items contained in this notice to the Attention: CDC Desk Officer, Office of Management and Budget, 725 17th Street NW, Washington, DC 20503 or by fax to (202) 395–5806. Provide written comments within 30 days of notice publication. Proposed Project Annual Progress Reports for Injury Control Research Centers (ICRC)— New—National Center for Injury Prevention and Control (NCIPC), Centers for Disease Control and Prevention (CDC). PO 00000 Frm 00038 Fmt 4703 Sfmt 4703 Background and Brief Description In 1987, the Centers for Disease Control and Prevention (CDC) and the National Center for Injury Prevention and Control (NCIPC) began funding Injury Control Research Centers (ICRCs) at academic research institutions throughout the United States. ICRCs focus on three core functions—research, training, and outreach—for issues of local and national importance, including the prevention of adverse childhood experiences; child abuse and neglect; drowning; drug overdose; intimate partner violence; older adult falls; sexual violence; suicide; traumatic brain injuries, and the promotion of transportation safety. ICRCs foster multidisciplinary strategies for addressing these complex problems and disseminating research findings. In addition to conducting cutting-edge, multidisciplinary research, ICRCs train and develop the current and next generation of researchers and public health professionals to help ensure that there is an adequate supply of qualified practitioners and researchers for advancing prevention research, addressing new problems, and reaching new populations across the nation. Finally, ICRCs work with states and communities to translate research findings into action. ICRCs provide partner organizations with technical assistance on programs, public health infrastructure, and the integration of resources at the local, state, and national levels. Areas of emphasis within each ICRC are determined by the expertise of the faculty and the public health needs and opportunities identified through the ICRC’s outreach activities. This collaborative approach is a vital component in the success of efforts to make an impact on population-level reduction in injury-related harm. ICRCs form a national network of expertise and innovation in injury prevention and control. ICRC grants are typically funded in five-year funding cycles. The Centers for Disease Control and Prevention (CDC) requests OMB approval to electronically collect annual progress report (APR) information and Success Stories from the 11 currently funded ICRCs. Grantees will report progress and activity information to CDC on an annual schedule. The information that will be collected will provide crucial data for program performance monitoring and will improve CDC’s ability to respond in a timely manner to requests for information about the program from the Department of Health and Human Services (HHS), the White House, Congress, and other sources. The E:\FR\FM\18NON1.SGM 18NON1

Agencies

[Federal Register Volume 89, Number 222 (Monday, November 18, 2024)]
[Notices]
[Pages 90699-90700]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-26784]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Solicitation of Nominations for Appointment to the Advisory 
Committee on Breast Cancer in Young Women

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: In accordance with the Federal Advisory Committee Act, the 
Centers for Disease Control and Prevention (CDC), within the Department 
of Health and Human Services (HHS), is seeking nominations for 
membership on the Advisory Committee on Breast Cancer in Young Women 
(ACBCYW). The ACBCYW consists of up to 15 experts in fields associated 
with breast cancer, disease prevention, early detection, diagnosis, 
public health, social marketing, genetic screening and counseling, 
treatment, rehabilitation, palliative care, and survivorship in young 
women, or in related disciplines with a specific focus on young women.

DATES: Nominations for membership on the ACBCYW must be received no 
later than December 16, 2024. Packages received after this time will 
not be considered for the current membership cycle.

ADDRESSES: All nominations should be mailed to Kimberly E. Smith, 
M.B.A., M.H.A., c/o ACBCYW Secretariat, Centers for Disease Control and 
Prevention, 3719 North Peachtree Road, Building 100, Chamblee, Georgia 
30341 or emailed to [email protected].

FOR FURTHER INFORMATION CONTACT: Kimberly E. Smith, M.B.A., M.H.A., 
Designated Federal Officer, National Center for Chronic Disease 
Prevention and Health Promotion, Centers for Disease Control and 
Prevention, 4770 Buford Highway NE, Mailstop S107-4, Atlanta, Georgia 
30341. Telephone: (404) 498-0073; Email: [email protected].

SUPPLEMENTARY INFORMATION: Nominations are sought for individuals who 
have the expertise and qualifications necessary to contribute to the 
accomplishment of the objectives of the Advisory Committee on Breast 
Cancer in Young Women (ACBCYW). Nominees will be selected based on 
expertise in the fields of breast health, breast cancer, disease 
prevention and risk reduction, survivorship (including metastatic 
breast cancer), hereditary breast and ovarian cancer, or in related 
disciplines with a specific focus on young women. Persons with personal 
experience with early onset breast cancer are also eligible to apply. 
This includes but may not be limited to breast cancer survivors 45 
years of age or younger, and caregivers of said persons. Federal 
employees will not be considered for membership. Members may be invited 
to serve up to four-year terms. Selection of members is based on 
candidates' qualifications to contribute to the accomplishment of 
ACBCYW objectives (https://www.cdc.gov/breast-cancer/php/advisory-committee/).
    Department of Health and Human Services (HHS) policy stipulates 
that committee membership be balanced in terms of points of view 
represented and the committee's function. Appointments shall be made 
without discrimination on the basis of age, race, ethnicity, gender, 
sexual orientation, gender identity, HIV status, disability, and 
cultural, religious, or socioeconomic status. Nominees must be U.S. 
citizens and cannot be full-time employees of the U.S. Government. 
Current participation on Federal workgroups or prior experience serving 
on a Federal advisory committee does not disqualify a candidate; 
however, HHS policy is to avoid excessive individual service on 
advisory committees and multiple committee memberships. Committee 
members are Special Government Employees, requiring the filing of 
financial disclosure reports at the beginning of and annually during 
their terms. The Centers for Disease Control and Prevention (CDC) 
reviews potential candidates for ACBCYW membership each year and 
provides a slate of

[[Page 90700]]

nominees for consideration to the Secretary of HHS for final selection. 
HHS notifies selected candidates of their appointment near the start of 
the term in December 2025, or as soon as the HHS selection process is 
completed. Note that the need for different expertise varies from year 
to year and a candidate who is not selected in one year may be 
reconsidered in a subsequent year.
    Candidates should submit the following items:
    [ssquf] Current curriculum vitae, including complete contact 
information (telephone numbers, mailing address, email address).
    [ssquf] At least one letter of recommendation from person(s) not 
employed by HHS. Candidates may submit letter(s) from current HHS 
employees if they wish, but at least one letter must be submitted by a 
person not employed by an HHS agency (e.g., CDC, National Institutes of 
Health, Food and Drug Administration).
    [ssquf] A short biography (150 words or less).
    Nominations may be submitted by the candidate or by the person/
organization recommending the candidate.
    The Director, Office of Strategic Business Initiatives, Office of 
the Chief Operating Officer, Centers for Disease Control and 
Prevention, has been delegated the authority to sign Federal Register 
notices pertaining to announcements of meetings and other committee 
management activities, for both the Centers for Disease Control and 
Prevention and the Agency for Toxic Substances and Disease Registry.

Kalwant Smagh,
Director, Office of Strategic Business Initiatives, Office of the Chief 
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2024-26784 Filed 11-15-24; 8:45 am]
BILLING CODE 4163-18-P


This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.